3rd ALS Drug Discovery Summit

3rd ALS Drug Discovery Summit

2N Pharma CEO, Preben Bruun-Nyzell, and CSO, Dr John Nieland, will participate in the 3rd ALS Drug Development Summit in Boston, 21-23 May 2024. This is a fantastic opportunity to engage with the world’s leading ALS drug development companies.
New article in npj Parkinson’s Disease

New article in npj Parkinson’s Disease

Congratulations to Dr Michael Sloth Trabjerg MD, 2N Pharma Co-Founder, CSO and Aalborg University Associate Professor Dr John Dirk Vestergaard Nieland, and collaborators on the publication of their newest article in npj Parkinson’s Disease. The article details their...
Bobby Soni, PhD

Bobby Soni, PhD

Bobby is the Chief Business Officer of the BioInnovation Institute in Copenhagen. He holds a BS in Biochemistry from the University of Rochester and a Ph.D. in Biology from the University of Virginia. Bobby has previously been a project leader/scientist at a biotech...